Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.
Press releases published on April 8, 2025
airSlate and RevSparkAI Join Forces to Transform RFP and Document Workflow Automation for the AI Era
EIN Presswire
·
April 8, 2025
BOSTON, MA, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- airSlate, a global leader in document workflow automation, today announced a strategic partnership with RevSparkAI, an AI-centric consultancy specializing in business process transformation. …
Censinet Appoints Cambrey Ware as Chief Commercial Officer
EIN Presswire
·
April 8, 2025
Industry Veteran Brings 20+ Years of Strategic Leadership and Success Scaling Healthcare SaaS Growth to Advance Censinet’s Leadership in Cyber GRC BOSTON, MA, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- Censinet, the leading provider of …
First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
GlobeNewswire
·
April 8, 2025
LA JOLLA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced enrollment of the …
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
GlobeNewswire
·
April 8, 2025
WARREN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, today announced that Mittul Mehta, Chief …
TransAlta to Host Annual Meeting of Shareholders and First Quarter 2025 Results Conference Call
GlobeNewswire
·
April 8, 2025
CALGARY, Alberta, April 08, 2025 (GLOBE NEWSWIRE) -- 2025 Annual Meeting of TransAlta Corporation Shareholders On Thursday, April 24, 2025, TransAlta Corporation (“TransAlta”) (TSX: TA) (NYSE: TAC) will hold its annual meeting of shareholders at 11:30 a.m. …
Zefiro Methane Corp. Appoints Correne Loeffler to its Board of Directors
GlobeNewswire
·
April 8, 2025
FORT LAUDERDALE, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) today announced the appointment of Correne Loeffler to the Company’s Board of Directors. …
NowVertical Group Wins 2025 Google Cloud Data & Analytics Partner of the Year for Latin America
GlobeNewswire
·
April 8, 2025
TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) ("NowVertical" or the "Company"), a leading data and AI solutions provider, announced today that it has received the 2025 Google Cloud Data …
Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease
GlobeNewswire
·
April 8, 2025
HUNTSVILLE, Ala., April 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today announced the closing of a $ …
Myriad Genetics Announces Inducement Awards
GlobeNewswire
·
April 8, 2025
SALT LAKE CITY, April 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today that in connection with the hiring of Mr. Donnelly as chief commercial officer, …
Satellogic Awarded $30 Million Contract for Its AI-First Constellation Services
GlobeNewswire
·
April 8, 2025
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Satellogic Inc. (NASDAQ: SATL), a leader in high-resolution Earth observation data, has been awarded a multi-year contract valued at $30 million to provide near-daily and ultra-low latency analytics from its …
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025
GlobeNewswire
·
April 8, 2025
PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
GlobeNewswire
·
April 8, 2025
SAN DIEGO, April 08, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases …
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy
GlobeNewswire
·
April 8, 2025
CALABASAS, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced that …
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities
GlobeNewswire
·
April 8, 2025
SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global Digital Holdings Inc., conducting business as QumulusAI …
Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting
GlobeNewswire
·
April 8, 2025
Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable Benefit of Tanruprubart (formerly ANX005) on Clinically Meaningful Measures across Multiple Stages of GBS Disease Education Campaign for Healthcare Providers called Move GBS Forward …
Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
April 8, 2025
NX-5948 assigned the nonproprietary name “bexobrutideg” U.S. FDA Orphan Drug Designation granted to bexobrutideg for the treatment of Waldenström macroglobulinemia Achieved $7M in milestones and a $15M license extension fee from ongoing collaboration with …
Pythian Wins 2025 Google Cloud Databases Partner of the Year for North America
GlobeNewswire
·
April 8, 2025
LAS VEGAS, April 08, 2025 (GLOBE NEWSWIRE) -- Pythian Services Inc. (“Pythian”), a leading global services company specializing in data, analytics, and AI solutions, announced today that it has received the 2025 Google Cloud Databases Partner of the Year …
Creatio Partners with Qu8 to Accelerate AI-Driven Digital Transformation in Poland
EIN Presswire
·
April 8, 2025
The collaboration brings AI-native, no-code CRM capabilities to more Polish organizations, helping them boost agility, efficiency, and growth BOSTON, MA, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- Creatio, a global vendor of an AI-native …
Fortinet Wins 2025 Google Cloud Technology Partner of the Year Award
GlobeNewswire
·
April 8, 2025
SUNNYVALE, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced it has won the 2025 Google Cloud Infrastructure Modernization Partner of the …
SADA Wins 2025 Google Cloud Global Partner of the Year Award for Google Workspace
GlobeNewswire
·
April 8, 2025
LAS VEGAS, April 08, 2025 (GLOBE NEWSWIRE) -- SADA, An Insight company, a leading business and technology consultancy and award-winning Google Cloud Premier level Partner across several product and engagement models, announced today it has received the …